{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:41:02Z","timestamp":1792694462830,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01070-3","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:33:34Z","timestamp":1792694014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Accelerated Registration of a New Anti-infective Combination in ASEAN Markets: Experience, Insights and Learnings on the ASEAN Joint Assessment (ASEAN JA)"],"prefix":"10.1007","author":[{"given":"Paul Marvin","family":"Quizon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patriz Miga","family":"Lintag-Raymundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Lee","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Tu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Iin","family":"Nurhayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wipada","family":"Rodtanaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3117-2945","authenticated-orcid":false,"given":"Tse Siang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"1070_CR1","unstructured":"Population of South Eastern Asia [Internet]. 2025. Available from: https:\/\/www.worldometers.info\/world-population\/south-eastern-asia-population\/. [cited 2 September 2025]."},{"key":"1070_CR2","unstructured":"Ing LYV, Yessi. Christian,David. ASEAN in the global economy: a half-century journey. 2024. Available from: https:\/\/www.eria.org\/news-and-views\/asean-in-the-global-economy--a-half-century-journey"},{"key":"1070_CR3","unstructured":"Pharmaceuticals market in ASEAN [Internet]. 2025. Available from: https:\/\/www.statista.com\/outlook\/hmo\/pharmaceuticals\/asean"},{"key":"1070_CR4","unstructured":"Secretariat A. ASEAN pharmaceutical regulatory policy: ASEAN secretariat. 2022. Available from: https:\/\/asean.org\/book\/asean-pharmaceutical-regulatory-policy\/"},{"key":"1070_CR5","unstructured":"WHO TRS 1033. Annex 10: good reliance practices in the regulation of medical products: high level principles and considerations. 2021."},{"key":"1070_CR6","doi-asserted-by":"publisher","first-page":"1467229","DOI":"10.3389\/fmed.2024.1467229","volume":"11","author":"AK Broojerdi","year":"2024","unstructured":"Broojerdi AK, Salvati AL, Abdelfattah MR, Dehaghi ROA, Sillo HB, Gaspar R. WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products. Front Med. 2024;11:1467229.","journal-title":"Front Med"},{"issue":"3","key":"1070_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s43441-024-00624-7","volume":"58","author":"G Geraci","year":"2024","unstructured":"Geraci G, Smith R, Hansford A, Johnsson E, Critchley H, Khaled LA, et al. Industry perceptions and experiences with the access consortium new active substance work-sharing initiative (NASWSI): survey results and recommendations. Therapeutic Innov Regul Sci. 2024;58(3):557\u201366.","journal-title":"Therapeutic Innov Regul Sci"},{"key":"1070_CR8","doi-asserted-by":"publisher","first-page":"898725","DOI":"10.3389\/fmed.2022.898725","volume":"9","author":"T Sithole","year":"2022","unstructured":"Sithole T, Mahlangu G, Walker S, Salek S. Pharmaceutical industry evaluation of the effectiveness and efficiency of the ZaZiBoNa collaborative medicines registration initiative: the way forward. Front Med. 2022;9:898725.","journal-title":"Front Med"},{"key":"1070_CR9","unstructured":"Ahmad RC, Azatyan T, Reggi S, Thanaphollert V. Prapassorn. Joint assessment of marketing authorization applications: cooperation among ASEAN drug regulatory authorities. 2021. Available from: https:\/\/globalforum.diaglobal.org\/issue\/september-2021\/joint-assessment-of-marketing-authorization-applications-cooperation-among-asean-drug-regulatory-authorities\/"},{"key":"1070_CR10","volume-title":"Procedure to applicants. 3rd WHO meeting to support ASEAN JA and Advocacy Workshop to Industry; 15 November 2024","author":"A Ramli","year":"2024","unstructured":"Ramli A. ASEAN NRAs sharing of experience on ASEAN JA procedures and proposals on ASEAN JA. Procedure to applicants. 3rd WHO meeting to support ASEAN JA and advocacy workshop to industry; 15 November 2024. Indonesia: Jakarta. 2024."},{"key":"1070_CR11","unstructured":"Por SGT, Ehab; Parado J, Yangyuennan P, Rahmawati. Optimizing ASEAN joint assessment lessons from a multistakeholder pilot. 2025. Available from: https:\/\/globalforum.diaglobal.org\/issue\/april-2025\/optimizing-asean-joint-assessment\/"},{"key":"1070_CR12","unstructured":"WHO Listed Authority (WLA.) WHO webpage [updated 22 Dec 2025]. Available from: https:\/\/www.who.int\/initiatives\/who-listed-authority-reg-authorities"},{"key":"1070_CR13","unstructured":"Valentin M. Overview of ASEAN JA Procedure. 3rd WHO meeting to support ASEAN JA and advocacy workshop to industry; Jakarta, Indonesia. 2024."},{"key":"1070_CR14","unstructured":"ASEAN Joint assessment. procedure for pharmaceutical products, frequently asked questions, revision 3. 2024."},{"key":"1070_CR15","unstructured":"ASEAN joint. assessment procedure for pharmaceutical products information for applicants. 2024."},{"key":"1070_CR16","unstructured":"List of priority products for JA activities. 2022. https:\/\/npra.gov.my\/images\/2023\/jacg\/List-of-Priority-Products-for-JA-Activities_Revision-2_Final-clean-version.pdf"},{"key":"1070_CR17","unstructured":"Mohd Sani N. Updates on ASEAN joint assessment procedure. DIA Singapore annual meeting; Singapore. 2025."},{"issue":"1","key":"1070_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41120-024-00102-2","volume":"10","author":"SSF Chong","year":"2024","unstructured":"Chong SSF, Ong SHM, Long SM, Kanno M, Harnpramukkul U, Wong KC, et al. Advancements in regulatory agility, regional collaboration, and digital transformation: insights from the Asia partnership conference of pharmaceutical associations (APAC). AAPS Open. 2024;10(1):14.","journal-title":"AAPS Open"},{"key":"1070_CR19","unstructured":"Aztreonam\/avibactam. Summary of product characteristics (SmPC) European medicines agency (EMA) webpage. 2024."},{"issue":"6","key":"1070_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cmi.2024.11.006","volume":"31","author":"G Sangiorgio","year":"2025","unstructured":"Sangiorgio G, Calvo M, Stefani S. Aztreonam and avibactam combination therapy for metallo-\u03b2-lactamase-producing gram-negative bacteria: a narrative review. Clin Microbiol Infect. 2025;31(6):971\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1070_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s43441-024-00620-x","volume":"58","author":"WL Chow","year":"2024","unstructured":"Chow WL, Salleh NAM, Kang TS. Access to innovative medicines: regulation change and factors associated with drug approval lag in Malaysia. Therapeutic Innov Regul Sci. 2024;58(3):528\u201338.","journal-title":"Therapeutic Innov Regul Sci"},{"key":"1070_CR22","unstructured":"ASEAN Joint. Assessment (AJA) for pharmaceuticals: How should it evolve? European Federation of pharmaceutical industries and associations (EFPIA). 2024."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01070-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:33:36Z","timestamp":1792694016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01070-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":22,"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01070-3","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"3 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employees of Pfizer Inc. (or its regional\/local affiliates) and may hold stock or stock options in Pfizer Inc. This manuscript describes routine work conducted as part of the authors\u2019 regular employment, and no dedicated, external, or additional funding was received for this study or the preparation of this article. The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}